CXCR4 Antibody (12G5) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB170H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-reported, Flow Cytometry, Neutralization
Label
HRP
Antibody Source
Monoclonal Mouse IgG2A Clone # 12G5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CP-MAC-infected SUP-T1 human T cell lymphoblastic lymphoma line
Accession # P61073
Accession # P61073
Specificity
Detects human CXCR4.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for CXCR4 Antibody (12G5) [HRP]
Application
Recommended Usage
CyTOF-reported
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from ascites
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CXCR4
Long Name
C-X-C Motif Chemokine Receptor 4
Alternate Names
CD184, D2S201E, FB22, Fusin, HM89, HSY3RR, LAP-3, LAP3, LCR1, LESTR, NPY3R, NPYRL, NPYY3R, WHIMS
Gene Symbol
CXCR4
Additional CXCR4 Products
Product Documents for CXCR4 Antibody (12G5) [HRP]
Product Specific Notices for CXCR4 Antibody (12G5) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...